ANI Pharmaceuticals's total assets for Q4 2025 were $1.44B, an increase of 2.29% from the previous quarter. ANIP total liabilities were $899.65M for the fiscal quarter, a -0.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.